Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Transl Psychiatry ; 2: e80, 2012 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-22832817

RESUMO

Individuals who abuse methamphetamine (MA) exhibit heightened aggression, but the neurobiological underpinnings are poorly understood. As variability in the serotonin transporter (SERT) gene can influence aggression, this study assessed possible contributions of this gene to MA-related aggression. In all, 53 MA-dependent and 47 control participants provided self-reports of aggression, and underwent functional magnetic resonance imaging while viewing pictures of faces. Participants were genotyped at two functional polymorphic loci in the SERT gene: the SERT-linked polymorphic region (SERT-LPR) and the intron 2 variable number tandem repeat polymorphism (STin2 VNTR); participants were then classified as having high or low risk for aggression according to individual SERT risk allele combinations. Comparison of SERT risk allele loads between groups showed no difference between MA-dependent and control participants. Comparison of self-report scores showed greater aggression in MA-dependent than control participants, and in high genetic risk than low-risk participants. Signal change in the amygdala was lower in high genetic risk than low-risk participants, but showed no main effect of MA abuse; however, signal change correlated negatively with MA use measures. Whole-brain differences in activation were observed between MA-dependent and control groups in the occipital and prefrontal cortex, and between genetic high- and low-risk groups in the occipital, fusiform, supramarginal and prefrontal cortex, with effects overlapping in a small region in the right ventrolateral prefrontal cortex. The findings suggest that the investigated SERT risk allele loads are comparable between MA-dependent and healthy individuals, and that MA and genetic risk influence aggression independently, with minimal overlap in associated neural substrates.


Assuntos
Agressão/fisiologia , Alelos , Transtornos Relacionados ao Uso de Anfetaminas/genética , Transtornos Relacionados ao Uso de Anfetaminas/fisiopatologia , Encéfalo/fisiopatologia , Estimulantes do Sistema Nervoso Central , Emoções/fisiologia , Predisposição Genética para Doença/genética , Variação Genética/genética , Genótipo , Metanfetamina , Rede Nervosa/fisiopatologia , Proteínas da Membrana Plasmática de Transporte de Serotonina/genética , Adulto , Transtornos Relacionados ao Uso de Anfetaminas/psicologia , Tonsila do Cerebelo/fisiopatologia , Mapeamento Encefálico , Estimulantes do Sistema Nervoso Central/efeitos adversos , Expressão Facial , Feminino , Lobo Frontal/fisiopatologia , Humanos , Íntrons/genética , Imageamento por Ressonância Magnética , Masculino , Metanfetamina/efeitos adversos , Pessoa de Meia-Idade , Repetições Minissatélites/genética , Lobo Occipital/fisiopatologia , Reconhecimento Visual de Modelos/fisiologia , Córtex Pré-Frontal/fisiopatologia , Síndrome de Abstinência a Substâncias/genética , Síndrome de Abstinência a Substâncias/fisiopatologia , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA